Stock screenerAll disclosures →
EDGAR →
CV
Conviction 60HealthcareScan · Thu, Jun 25, 2026CV$6.99-1.41%
ResistanceSupportVol 14Vol MA14 191.43K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.99
Change-1.41%
Gap-1.97%
Rel volume6.69×
Avg volume170.88K
Avg $ vol1.19M
SMA 206.93
SMA 506.73
SMA 2006.34
Price vs 50+3.81%
Price vs 200+10.22%
MA stackbullish
50/200 cross—
Supertrenddown · 7.59
RSI (14)52
MACD hist-0.02
MACD crossbear · 6d
Stoch %K / %D45 / 36
ADX (14)11
+DI / −DI24 / 19
RSI divergence—
MACD divergence—
ATR %+7.16%
ADR %6.94%
52w high14.42
52w low3.50
From 52w high-51.53%
Above 52w low+99.71%
New 52w highNo
SqueezeOn · 24d
Bollinger width17.92%
%B0.55
Donchian pos44.71%
Donchian high7.80
Donchian low6.34
AVWAP (52w high)7.27
vs AVWAP high-3.80%
AVWAP (52w low)7.38
vs AVWAP low-5.33%
OBV trendDown
Chaikin MF (20)-0.21
Today vs 20d6.69×
Avg vol (14d)191.43K
Avg vol (20d)170.88K
Avg $ vol (20d)1.19M
Market cap349.25M
RS 3m (vs SPY)-30.67%
RS 6m (vs SPY)-54.15%
RS line new highNo
Trend template—
Technical rank54.1
1 week+7.54%
1 month+5.59%
3 months-15.48%
6 months-46.60%
1 year—
YTD-31.74%
P/E-13.80
P/B17.27
P/S25.77
P/FCF-15.21
EPS-1.03
Div yield—
ROE-125.20%
ROA-97.57%
Debt/Eq—
Current4.57
EV/EBITDA-13.80
Gross margin52.92%
Net margin-186.77%
Rev growth15.29%
EPS growth-27.22%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value349.25M
Revenue2.79M
Net income-7.03M
Gross profit1.33M
Free cash flow-22.95M
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
ExchangeNasdaq
Shares out49.96M
Employees99
ListedWed, Jul 2, 2025
Free float30.76M
Float %65.7%
Short interest1.35M
Days to cover15.6d
Short volume66.9%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction60 / 100
Pattern quality—
Tech rank54.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.77
Support6.27
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CV
No recent disclosed trades by Congress in CV. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CV · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Wang Kang-Huai See Remarks · Stock Option (right to buy) · 2026-06-01 | Grant | 358.34K | $0 | 2026-06-01 | 2026-06-03 |
Garcia David Michael Sr. VP of Finance · Stock Option (right to buy) · 2026-06-01 | Grant | 92.21K | $0 | 2026-06-01 | 2026-06-03 |
Atkinson Douglas Patrick Head of Global Sales · Stock Option (right to buy) · 2026-06-01 | Grant | 158.08K | $0 | 2026-06-01 | 2026-06-03 |
Atkinson Douglas Patrick Head of Global Sales · Common Stock · 2026-05-05 | Exercise | 34.79K | $20K | 2026-05-05 | 2026-05-06 |
Atkinson Douglas Patrick Head of Global Sales · Stock Option (right to buy) · 2026-05-05 | Exercise | 34.79K | $0 | 2026-05-05 | 2026-05-06 |
Atkinson Douglas Patrick Head of Global Sales · Common Stock · 2026-05-04 | Exercise | 36.04K | $10K | 2026-05-04 | 2026-05-06 |
Atkinson Douglas Patrick Head of Global Sales · Stock Option (right to buy) · 2026-05-04 | Exercise | 36.04K | $0 | 2026-05-04 | 2026-05-06 |
Atkinson Douglas Patrick Head of Global Sales · Stock Option (right to buy) · 2026-05-04 | Exercise | 30.03K | $0 | 2026-05-04 | 2026-05-06 |
Atkinson Douglas Patrick Head of Global Sales · Common Stock · 2026-05-04 | Exercise | 6.5K | $4K | 2026-05-04 | 2026-05-06 |
Atkinson Douglas Patrick Head of Global Sales · Stock Option (right to buy) · 2026-05-04 | Exercise | 6.5K | $0 | 2026-05-04 | 2026-05-06 |
SEC filings
EDGAR filings in CV · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.